Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid for Hemostasis in Mohs Surgery
NCT04541303Phase 1Completed
- Sponsor
- University of Missouri
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by University of Missouri. Primary endpoints: Frequency of Postoperative Hemorrhagic Complications at 3 days, Rate of Clinic Evaluations of Postoperative Hemorrhagic Complications at 3 days and 1 more. Started Oct 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT04541303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04541303.